Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNY - Regeneron's Praluent injection gets FDA approval to treat kids with genetic form of high cholesterol

SNY - Regeneron's Praluent injection gets FDA approval to treat kids with genetic form of high cholesterol

Sanofi

2024-03-11 07:52:45 ET

Regeneron Pharmaceuticals ( NASDAQ: REGN ) has received approval from the U.S. Food & Drug Administration (FDA) for its Praluent (alirocumab) injection to treat children with genetic form of high cholesterol....

For further details see:

Regeneron's Praluent injection gets FDA approval to treat kids with genetic form of high cholesterol
Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...